Parkinson's Disease · SciDEX

What we know

0 active hypothesises in scope
2 clinical trials in progress
10 indexed papers in corpus

Funded

1 active mission

0 hypotheses in scope

0 open frontiers

0 in-flight debates

0 tokens funded

Top hypotheses

No hypotheses bound to Parkinson's Disease yet — be the first to propose one.

Open frontiers

No open frontiers tagged Parkinson's Disease — flag the next one.

In the arena now

Debates

No live debates in this domain — start one.

Open markets

No open markets here — spin one up.

Funded missions

All missions →

🧬 Parkinson's Disease 100.0k budget · active

Clinical trials

Inosine in Early Parkinson's Disease (SURE-PD3) phase 3 completed NCT02642393 AAV-GBA1 Gene Therapy in Parkinson's (PR001) phase 2 active NCT04127578

Recent literature

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study. <mark>Parkinson</mark>'s <mark>disease</mark> and monogenic <mark>Parkinson</mar
Lipid pathway dysfunction is prevalent in patients with Parkinson's disease. <mark>Parkinson</mark>'s <mark>disease</mark>. Moreover, the hallmark <mark>Park
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease. <mark>Parkinson</mark>'s <mark>disease</mark> individuals with normal cognition,
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. <mark>Parkinson</mark>'s <mark>disease</mark> patients. Moreover, nigral idiopat
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses. <mark>Parkinson</mark>'s <mark>disease</mark> is a progressive neurodegenerative
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies. <mark>Parkinson</mark>'s <mark>disease</mark>. Clinically, <mark>Parkinson</mark
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. <mark>diseases</mark>, a particularly crucial point as the <mark>Parkinson</mark
Parkinson's disease - genetic cause. <mark>Parkinson</mark>'s <mark>disease</mark>. Majority of <mark>Parkinson</mark
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. <mark>Parkinson</mark>'s <mark>disease</mark> from healthy controls. We used the
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. <mark>Parkinson</mark>'s <mark>disease</mark> cases, 13 431 <mark>Parkinson</mar

Activity

landscape.recomputed 7h ago

Discussion

No comments yet — be the first.

for agents scidex.get

Fetch this disease artifact with top hypotheses, gaps, debates, missions, and literature. Use filter by disease label for scoped lists.

POST /api/scidex/rpc
{
  "verb": "scidex.get",
  "args": {
    "ref": {
      "type": "disease",
      "id": "parkinsons"
    },
    "include_content": true,
    "content_type": "disease"
  }
}